Search - tctmd.com

Displaying 1 - 20 of 9023

Sort: Relevancy | Date

News Daily News

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Michael O'Riordan

March 23, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News CRT 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

L.A. McKeown

March 19, 2026

LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF

News Conference News

Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF

Caitlin E. Cox

March 18, 2026

News Daily News

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines

Caitlin E. Cox

March 18, 2026

News Conference News CRT 2026

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

L.A. McKeown

March 17, 2026

News Conference News CRT 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

L.A. McKeown

March 16, 2026

News Conference News CRT 2026

SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type

L.A. McKeown

March 16, 2026

News Daily News

Suspended Lead Suit Brings Radiation Exposure Down to Zero for Many Structural Imagers

Yael L. Maxwell

March 13, 2026

News Daily News

Experience Matters as Ross Procedure Gains Popularity in North America

Michael O'Riordan

March 06, 2026

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

L.A. McKeown

March 04, 2026

News Conference News THT 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

Todd Neale

March 04, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

Presentation THT Abstracts 2026

Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Cardiogenic Shock

Presenter: Omaima Chaudhary

March 02, 2026

Presentation THT Abstracts 2026

Rethinking Rheumatic Mitral Stenosis: Repeat Percutaneous Mitral Valve Repair as a Viable Option

Presenter: Ezra Schneier

March 02, 2026

Presentation THT Abstracts 2026

Sex-Based Differences on Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis

Presenter: Mark Darkwah

March 02, 2026

Presentation THT Abstracts 2026

Successful ViV-TAVR on a Deteriorated Mosaic Bioprosthetic Valve: A Promising Alternative to High-Risk Surgical Repair

Presenter: Rani Marhaba

March 02, 2026

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

News Conference News EAPCI 2026

AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing

Caitlin E. Cox

February 25, 2026

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

Advertisement

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

What’s Going to Be Hot at ACC 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

CARPOOL Radial Access as Good as Femoral in PAD Procedures

SOLVE-TAVI: Patient Sex, for the Most Part, Doesn’t Sway Outcomes by Valve Type

Suspended Lead Suit Brings Radiation Exposure Down to Zero for Many Structural Imagers

Experience Matters as Ross Procedure Gains Popularity in North America

CRT 2026: What to Expect in Washington, DC

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

TCTMD’s Top 10 Most Popular Stories for February 2026

Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Cardiogenic Shock

Rethinking Rheumatic Mitral Stenosis: Repeat Percutaneous Mitral Valve Repair as a Viable Option

Sex-Based Differences on Clinical Outcomes After Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis

Successful ViV-TAVR on a Deteriorated Mosaic Bioprosthetic Valve: A Promising Alternative to High-Risk Surgical Repair

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

AVR in Asymptomatic AS: Look to the ‘Sweet Spot’ for Timing

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content